S
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K358.1 KBScopus BioPharma Inc.Aug 18, 5:16 PM ET·0001104659-23-093554
- 8-K195.5 KBScopus BioPharma Inc.Aug 11, 5:01 PM ET·0001104659-23-090580
- 10-Q4.3 MBScopus BioPharma Inc.Aug 11, 5:00 PM ET·0001410578-23-001787
- 10-Q3.9 MBScopus BioPharma Inc.May 12, 5:15 PM ET·0001410578-23-001110
- 10-K/A433.6 KBScopus BioPharma Inc.Apr 28, 5:00 PM ET·0001104659-23-053138
- 10-K7.2 MBScopus BioPharma Inc.Apr 14, 5:00 PM ET·0001410578-23-000666
- 8-K199.2 KBScopus BioPharma Inc.Dec 16, 6:05 AM ET·0001104659-22-127517
- 8-K199.6 KBScopus BioPharma Inc.Dec 2, 5:15 PM ET·0001104659-22-124179
- 10-Q5.4 MBScopus BioPharma Inc.Nov 21, 5:16 PM ET·0001410578-22-003519
- 8-K266.7 KBScopus BioPharma Inc.Oct 20, 5:15 PM ET·0001104659-22-110330
Insiders
10- Battleman David S.Director
- Buckel David A.Director
- Gibson Robert JDirector, Vice Chairman
- Greenspan Ira ScottDirector, Executive Committee Chairman, 10% Owner
- Hofstein RaphaelDirector
- Hopper PaulDirector
- Horsager Alan MSee Remarks
- Lamstein Joshua RDirector, Chairman, 10% Owner
- Russell LesleyDirector
- Sanghrajka Ashish PDirector, President
Tickers
No tickers on record
Addresses
business
420 LEXINGTON AVENUE, SUITE 300
NEW YORK, NY, 10170
mailing
420 LEXINGTON AVENUE, SUITE 300
NEW YORK, NY, 10170